Ciprofloxacin Lactate Injection 200mg/100mL

Ciprofloxacin Lactate Injection 200mg/100mL: What the Published Guidance Says

A broad portfolio spanning the WHO Access and Watch groups, supplied with the documentation that stewardship programmes and national tenders require.

Ciprofloxacin Lactate Injection 200mg/100mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Antibacterials range overview.

• Watch group — supplied, but under stewardship Azithromycin, ceftriaxone, ciprofloxacin, clarithromycin, cefuroxime, netilmicin, norfloxacin, ofloxacin, neomycin and kanamycin sit in the Watch group, reserved for a limited number of specific infectious syndromes and monitored for resistance. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
• AWaRe is the framework buyers and stewards now work to WHO's AWaRe classification divides antibiotics into Access, Watch and Reserve. Access agents are described as those that should be widely available, affordable and quality-assured to improve access and promote appropriate use. Watch agents carry higher resistance potential and should be prioritised as targets of stewardship programmes and monitoring. WHO Antibiotics Portal — AWaRe
• Access group — the empirical workhorses The WHO AWaRe classification places amoxicillin, amoxicillin + clavulanic acid, ampicillin, clindamycin, gentamicin, metronidazole, chloramphenicol and doxycycline in the Access group. These are the medicines expected to be available in every functioning health system. WHO AWaRe (Access, Watch, Reserve) classification of antibiotics

These points are quoted because they shape how Ciprofloxacin Lactate Injection 200mg/100mL is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Ordering Parameters for Ciprofloxacin Lactate Injection 200mg/100mL

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Levofloxacin Lactate Injection 100ml:300mg, Amoxicillin Powder for Injection 1g, Netilmicin Injection 100mg/2ml, Metronidazole Injection 5mL:25mg, Gentamicin Injection 2mL:80mg, Clindamycin Injection 300mg/2mL, Ceftriaxone Powder for Injection 1g, Metronidazole Injection 500mg 100ml.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Ciprofloxacin Lactate Injection 200mg/100mL is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)
• Testing for heavy metals and elemental impurities
• Testing for packaging integrity and seal testing
• Testing for description and identification

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

• Pack size: 100mL sterile plastic infusion bag (PVC or non-PVC) or glass bottle. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store below 25°C, protected from light. Do not freeze. Keep container in overwrap until use (for plastic bags)..
• Shelf life: 24 months (unopened). Stability data for the marketed pack is included in the dossier.
• Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
• Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

• Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
• CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
• Site Master File and GMP certificate for the manufacturing workshops.
• Method validation, stability protocol and the shelf-life justification for the marketed pack.
• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.

This page describes Ciprofloxacin Lactate Injection 200mg/100mL as a product of the antibacterials classified in the WHO AWaRe framework family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Products Commonly Ordered with Ciprofloxacin Lactate Injection 200mg/100mL

• Levofloxacin Lactate Injection 100ml:300mg — 100mL
• Amoxicillin Powder for Injection 1g — 1g
• Netilmicin Injection 100mg/2ml — 100mg/2mL
• Metronidazole Injection 5mL:25mg — 25mg/5mL
• Gentamicin Injection 2mL:80mg — 80mg/2mL
• Clindamycin Injection 300mg/2mL — 300mg/2mL

Browse the full Antibacterials range; all Injectables; the complete product catalogue.